Clinical Trials
3 trialsNCT01296555 2024-07-31
A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma (NHL) and in Combination With Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer
Genentech, Inc.
Phase 1 Terminated
NCT03043430 2023-04-25
Intranasal Ketamine for Anxiolysis in Pediatric Emergency Department Patients
Brooke Army Medical Center
Phase 4 Terminated
NCT01209832 2019-03-18
A Tasisulam and Midazolam Drug Interaction Study in Cancer Patients
Eli Lilly and Company
Phase 1 Terminated